ArticleThe oncologist2014

Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.

Joshua A Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.